-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The global medical technology giant BD Medical and its upstream and downstream partners will participate in the 2021 China International Medical Equipment Expo (hereinafter referred to as "CMEF") to discuss the new policies, new technologies, new medical treatments, new generations and new generations facing the industry under the new situation.
Ecology
.
The guests who participated in the BD Biomedical “Insight into the New Future of Interventional Medicine” theme forum include experts in health economics and health policy, and Professor Jiangnan Cai, the founder and executive chairman of Shanghai Chuangqi Health Development Research Institute; Song Chengli, Professor of the School of Food Science and Director of Shanghai Chuangqi Health Development Research Institute; Fu Weiguo, Director of Vascular Surgery, Zhongshan Hospital Affiliated to Fudan University; Li Wentao, Director of Interventional Therapy Department, Fudan University Cancer Hospital; Boston Consulting Group Managing Director and Partner Jia Fangren; Director General of Yunfeng Fund Manager Li Wengang; Ruihua Kangyuan Co-founder and CFO Zheng Yunsheng; Xiangsheng Medical General Manager Mo Ruoli; Sanofi China Cardiovascular and Mature Products Division General Manager Liu Jing; Ping An Dianchuang Leasing General Manager Jia Hongshuo, etc.
The development of medical technology in the "14th Five-Year Period" is not only related to people's livelihood and health, so as to better protect patients with medical treatment; it is also an important aspect of accelerating the construction of a new dual-cycle development pattern driven by innovation
.
In response to the requirement of "strengthening medical technology innovation" put forward by the "Healthy China 2030" national policy, BD Medical actively participates in the promotion of research and innovation cooperation with colleges and universities, scientific research institutes, medical institutions, etc.
Deng Jianmin, senior vice president of BD Medical and general manager of the Greater China region, said at the forum: "BD Medical has always adhered to the concept of'rooting China and serving China (in china for china)'.
In recent years, it has established a localized service From R&D to production to supply chain management, we are the beneficiaries of this process, and we are also willing to continue to further explore local innovation in the future, and work with external partners to empower upstream and downstream industries to jointly build China's medical industry.
The ecosphere is the value orientation that leads the development of the health industry and benefits more medical workers and patients
.
"
The Bidi Medical exhibition area of this year's CMEF has created four simulated real-life spaces in the hospital with the theme of "Interventional New Ecology-Smart Hospital-Accurate Diagnosis-ICU Safety Care", and the newly launched automatic microbial sample processing system Kiestra InoqulA, FACSLyric and FACSDuet, which represent the new era of fully automated standardized flow laboratories, and Arctic Sun, a target temperature management system that accurately masters life temperature, have focused on improving the clinical results and experience of patients, protecting patients and medical staff, and controlling overall medical costs.
BD’s innovative peripheral vascular intervention solution, the Rotarex rotary catheter and its supporting power equipment, which debuted at the exhibition for the first time, attracted widespread attention on the opening day.
During the CMEF forum, BD Medical also joined hands with HiMed Medical Innovation Camp, which has rich experience in the field of medical innovation incubation, to officially launch the BD Medical Innovation Incubation Project, introducing the international cutting-edge innovation theory system - Stanford Biodesign , With the industry’s strongest mentor team, open and diversified cooperation model and powerful shared service resources, it provides one-stop incubation including early guidance, capital and resource matching for early medical innovation projects in the intervention field to improve domestic medical care The quality of scientific and technological innovation, and accelerate the mature commercial transformation of innovative scientific research results
The launch of the "Medical Innovation Camp" also marks that BD Medical’s local innovation strategy has entered a new stage, from establishing a local value chain to building a new ecosystem of open innovation.
